Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance

The dismal lethality of lung cancer is due to late stage at diagnosis and inherent therapeutic resistance. The incorporation of targeted therapies has modestly improved clinical outcomes, but the identification of new targets could further improve clinical outcomes by guiding stratification of poor-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zhang, Chunyu, Elkahloun, Abdel G., Robertson, Matthew, Gills, Joell J., Tsurutani, Junji, Shih, Joanna H., Fukuoka, Junya, Hollander, M. Christine, Harris, Curtis C., Travis, William D., Jen, Jin, Dennis, Phillip A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3161069/
https://ncbi.nlm.nih.gov/pubmed/21887332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0023849
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak